Expertise in
8
conditions

Anne Uyttebroeck

UZ Leuven
Leuven, VLG, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
UZ Leuven
Leuven, VLG, BE 

Overview

Anne Uyttebroeck practices practicing medicine in Leuven, Belgium.

Ms. Uyttebroeck is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult T-Cell Leukemia, Hodgkin Lymphoma, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 167 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

UZ Leuven
Leuven, VLG 3000, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Enrollment Status: Recruiting
Publish Date: August 12, 2026
Intervention Type: Drug
Study Drugs: Doxorubicin, Vincristine, Dexamethasone, Inotuzumab, Imatinib, 6-Tioguanine, Blinatumomab
Study Phase: Phase 3
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2026
Intervention Type: Drug, Procedure, Other, Biological
Study Drugs: Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Dexrazoxane Hydrochloride, Doxorubicin, Etoposide, Filgrastim, Ifosfamide, Imatinib Mesylate, Leucovorin Calcium, Mercaptopurine, Methotrexate, Methylprednisolone, Pegaspargase, Prednisolone, Hydrocortisone, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3
Intergroup Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Evaluation of Rituximab Efficacy and Safety in High Risk Patients - Phase III Trial
Intergroup Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Evaluation of Rituximab Efficacy and Safety in High Risk Patients - Phase III Trial
Enrollment Status: Completed
Publish Date: February 09, 2026
Intervention Type: Drug
Study Drugs: Vincristine, Cyclophosphamide, Methotrexate, Doxorubicin, Cytarabine, Ara-C, Rituximab
Study Phase: Phase 3
View 2 Less Clinical Trial

167 Total Publications

Change in Mental Health and Resilience in Childhood Cancer Survivors After Attending a Person-Centred State-of-the-Art Late Effects Clinic-on Behalf of the PanCareFollowUp Consortium.
Change in Mental Health and Resilience in Childhood Cancer Survivors After Attending a Person-Centred State-of-the-Art Late Effects Clinic-on Behalf of the PanCareFollowUp Consortium.
Journal: Pediatric blood & cancer
Published: May 29, 2026

Frequently Asked Questions about Anne Uyttebroeck

Is Anne Uyttebroeck a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?

MediFind is an objective health platform that identifies experts based on real-world data. Anne Uyttebroeck is classified as an Distinguished expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anne Uyttebroeck participate in research or clinical trials?

Yes. Anne Uyttebroeck has published 167 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Anne Uyttebroeck's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Uyttebroeck's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile